The Bio Materials Research Cluster
The Bio Materials Research Cluster focuses on structured biological materials and systems based on molecular and cellular building blocks that range from molecular ensembles to cells/cell aggregates, tissues, and organs, and the interface with non-biological materials such as implants, drugs and their combination.
Our knowledge of interactions at the interface of the body and its outer environment, biomaterials and the physiological microenvironment, and biomaterials’ own components will help overcoming scientific and engineering challenges and help reducing the use of animal models by providing robust functional in vitro and in silico models.
Modelling, design and synthesis of innovative biomaterials validated within in vitro mimetic models of diseases, high-resolution imaging and characterisation tools, and functional biomaterials such as polymers, ceramics, metals and biologicals will pave the way for the development of new therapeutic strategies and solutions. To this effect, molecular characterisation and processing are linked with process engineering as well as molecular and nanomaterials science through the respective Bernal Research Clusters not only for the production and study of biological and bioactive molecules but also to obtain new understanding of molecular and cellular properties in physiological environments. The Cluster’s ground breaking contributions to the field of biopiezoelectricity and regulatory approval of new bioactive bone cement are current examples of the strength and success of its holistic approach to today’s medicine.
The specific goals of the Bio Materials Cluster are
- To challenge currently accepted norms in disease diagnosis and therapy by converging knowledge and expertise from multiple disciplines targeting cancer, neurological diseases, aging related diseases and community health.
- To understand, design and manufacture innovative biomaterials with superior therapeutic performance.
- Leveraging national and European stakeholders’ engagement to create wider international impact in the area of Bio Materials
The Biomaterials Cluster comprises 25 Principal Investigators (Andreas Grabrucker, Andy Stewart, Christophe Silien, Damien Thompson, David Newport, Emmet O’Reilly, Jacques Huyghe, Jakki Cooney, John Mulvihill, Kieran McGourty, Luis Padrela, Michael Walsh, Ning Liu, Patrick Kiely, Sarah Hudson, Tewfik Soulimane, Tofail Syed, Tony Pembroke, George Barreto, Sean Fair, Eamonn deBarra, Dick Fitzgerald, Ioannis Zabetakis, Alexandros Tsoupras, Eibhlís O’Connor).
The group currently hosts 51 PhD students and 23 postdoctoral researchers.